第 1 到 63 筆結果,共 63 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2024 | Outcomes after fertility-sparing surgery of early-stage ovarian cancer: A nationwide population-based study | Lee, Chia-Yi; CHUN-JU CHIANG ; YI-JOU TAI ; HENG-CHENG HSU ; YU-LI CHEN ; YING-CHENG CHIANG ; CHIA-YING WU ; WEN-CHUNG LEE ; HSIAO-LIN HWA ; WEN-FANG CHENG | Cancer medicine | |||
2 | 2024 | The Role of Chitinase-3-like Protein-1 (YKL40) in the Therapy of Cancer and Other Chronic-Inflammation-Related Diseases | Chang, Ming-Cheng; Chen, Chun-Tang; Chiang, Ping-Fang; YING-CHENG CHIANG | Pharmaceuticals (Basel, Switzerland) | |||
3 | 2023 | Prognostic nutritional index and neutrophil-lymphocyte ratio predict toxicities and prognosis in patients with cervical cancer treated with curative radiochemotherapy | JENNY LING-YU CHEN ; Huang, Chao-Yuan; I-LUN SHIH ; Liou, Yih-Mei; YI-JOU TAI ; YING-CHENG CHIANG ; CHING-YING KUO | Journal of the Formosan Medical Association = Taiwan yi zhi | |||
4 | 2023 | Diverse genetic spectrum among patients who met the criteria of hereditary breast, ovarian and pancreatic cancer syndrome | PO-HAN LIN ; YU-WEN TIEN ; WEN-FANG CHENG ; YING-CHENG CHIANG ; Wu, Chien-Huei; Yang, Karen; CHIUN-SHENG HUANG | Journal of Gynecologic Oncology | 0 | ||
5 | 2023 | Outcome and prognostic factors of unexpected ovarian carcinomas | Cheng, Ching-Yu; HENG-CHENG HSU ; YI-JOU TAI ; YING-CHENG CHIANG ; YU-LI CHEN ; WEN-FANG CHENG | Cancer medicine | 1 | 1 | |
6 | 2023 | Age-specific trend and birth cohort effect on different histologic types of uterine corpus cancers | YI-JOU TAI ; CHUN-JU CHIANG ; YING-CHENG CHIANG ; CHIA-YING WU ; WEN-CHUNG LEE ; WEN-FANG CHENG | Scientific reports | 1 | 1 | |
7 | 2022 | Develop companion radiopharmaceutical YKL40 antibodies as potential theranostic agents for epithelial ovarian cancer | Chang, Ming-Cheng; Chiang, Ping-Fang; Kuo, Yu-Jen; Peng, Cheng-Liang; I-CHUN CHEN ; Huang, Chia-Yen; CHI-AN CHEN ; YING-CHENG CHIANG | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 1 | 1 | |
8 | 2022 | Leiomyomatosis peritonealis disseminata in laparoscopic port site and abdomino-pelvic cavity: A case report | Hsieh, Yun-Chiao; Kuo, Po-Yen; YING-CHENG CHIANG | Radiology case reports | 2 | 0 | |
9 | 2022 | Preoperative magnetic resonance imaging predicts clinicopathological parameters and stages of endometrial carcinomas | CHIA-YING WU ; YI-JOU TAI ; I-LUN SHIH ; YING-CHENG CHIANG ; YU-LI CHEN ; HENG-CHENG HSU ; WEN-FANG CHENG | Cancer medicine | 4 | 2 | |
10 | 2021 | A DNA Damage Response Gene Panel for Different Histologic Types of Epithelial Ovarian Carcinomas and Their Outcomes | YING-CHENG CHIANG ; PO-HAN LIN ; TZU-PIN LU ; KUAN-TING KUO ; YI-JOU TAI ; HENG-CHENG HSU ; CHIA-YING WU ; Lee, Chia-Yi; Shen, Hung; CHI-AN CHEN ; WEN-FANG CHENG | Biomedicines | 3 | 3 | |
11 | 2021 | Hyaluronan-Loaded Liposomal Dexamethasone-Diclofenac Nanoparticles for Local Osteoarthritis Treatment | Chang, Ming-Cheng; Chiang, Ping-Fang; Kuo, Yu-Jen; Peng, Cheng-Liang; Chen, Kuan-Yin; YING-CHENG CHIANG | International journal of molecular sciences | 29 | 22 | |
12 | 2021 | Factors Influencing the Discordancy Between Intraoperative Frozen Sections and Final Paraffin Pathologies in Ovarian Tumors | Shen, Hung; HENG-CHENG HSU ; YI-JOU TAI ; KUAN-TING KUO ; CHIA-YING WU ; YEN-LING LAI ; YING-CHENG CHIANG ; YU-LI CHEN ; WEN-FANG CHENG | Frontiers in oncology | 5 | 5 | |
13 | 2021 | Ovarian cancer risk score predicts chemo-response and outcome in epithelial ovarian carcinoma patients | Lu, Hsiao Yun; YI-JOU TAI ; YU-LI CHEN ; YING-CHENG CHIANG ; Hsu, Heng Cheng ; WEN-FANG CHENG | Journal of gynecologic oncology | 5 | 5 | |
14 | 2021 | Homologous Recombination Deficiency Assays in Epithelial Ovarian Cancer: Current Status and Future Direction | YING-CHENG CHIANG ; PO-HAN LIN ; WEN-FANG CHENG | Frontiers in Oncology | 14 | 13 | |
15 | 2021 | Increased risk of second primary malignancies among endometrial cancer survivors receiving surgery alone: A population-based analysis | YEN-LING LAI ; CHUN-JU CHIANG ; YU-LI CHEN ; You, San-Lin; Chen, Yun-Yuan; YING-CHENG CHIANG ; YI-JOU TAI ; HENG-CHENG HSU ; CHI-AN CHEN ; WEN-FANG CHENG | Cancer medicine | 3 | 3 | |
16 | 2020 | Outcome and Subsequent Pregnancy after Fertility-Sparing Surgery of Early-Stage Cervical Cancers | Lee, Chia-Yi; YU-LI CHEN ; YING-CHENG CHIANG ; Cheng, Ching-Yu; YEN-LING LAI ; YI-JOU TAI ; HENG-CHENG HSU ; HSIAO-LIN HWA ; WEN-FANG CHENG | International journal of environmental research and public health | 3 | 3 | |
17 | 2019 | Developing a Prognostic Gene Panel of Epithelial Ovarian Cancer Patients by a Machine Learning Model | TZU-PIN LU ; KUAN-TING KUO ; Chen, Ching-Hsuan; Chang, Ming-Cheng; Lin, Hsiu-Ping; Hu, Yu-Hao; YING-CHENG CHIANG ; WEN-FANG CHENG ; CHI-AN CHEN | Cancers | 17 | 14 | |
18 | 2019 | Bevacizumab dose affects the severity of adverse events in gynecologic malignancies | Lee S.-P.; HENG-CHENG HSU ; YI-JOU TAI ; YU-LI CHEN ; YING-CHENG CHIANG ; CHI-AN CHEN ; WEN-FANG CHENG | Frontiers in Pharmacology | 15 | 17 | |
19 | 2019 | Immune checkpoint Ab enhances the antigen-specific anti-tumor effects by modulating both dendritic cells and regulatory T lymphocytes | Sun N.-Y.; U-LI CHEN ; Lin H.-W.; YING-CHENG CHIANG ; Chang C.-F.; YI-JOU TAI ; CHI-AN CHEN ; WEI-ZEN SUN ; CHUNG-LIANG CHIEN ; WEN-FANG CHENG | Cancer Letters | 12 | 13 | |
20 | 2019 | Impact of adjuvant modalities on survival in patients with advanced stage endometrial carcinoma: A retrospective analysis from a tertiary medical center | YI-JOU TAI ; HENG-CHENG HSU ; YING-CHENG CHIANG ; YU-LI CHEN ; CHI-AN CHEN ; WEN-FANG CHENG | International Journal of Environmental Research and Public Health | 9 | 8 | |
21 | 2019 | Blockade of PD-L1 enhances cancer immunotherapy by regulating dendritic cell maturation and macrophage polarization | Sun N.-Y.; YU-LI CHEN ; Wu W.-Y.; Lin H.-W.; YING-CHENG CHIANG ; Chang C.-F.; YI-JOU TAI ; HENG-CHENG HSU ; CHI-AN CHEN ; WEI-ZEN SUN ; WEN-FANG CHENG | Cancers | 39 | 38 | |
22 | 2019 | CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells | Lin H.-W.; YING-CHENG CHIANG ; Sun N.-Y.; YU-LI CHEN ; Chang C.-F.; YI-JOU TAI ; CHI-AN CHEN ; WEN-FANG CHENG | Endocrine-Related Cancer | 12 | 13 | |
23 | 2018 | CDH1, DLEC1 and SFRP5 methylation panel as a prognostic marker for advanced epithelial ovarian cancer | Lin, Han-Wei; Fu, Chi-Feng; Chang, Ming-Cheng; TZU-PIN LU ; Lin, Hsiu-Ping; YING-CHENG CHIANG ; CHI-AN CHEN ; WEN-FANG CHENG | Epigenomics | 10 | 9 | |
24 | 2018 | Factors predicting parametrial invasion in patients with early-stage cervical carcinomas | HENG-CHENG HSU ; YI-JOU TAI ; YU-LI CHEN ; YING-CHENG CHIANG ; CHI-AN CHEN ; WEN-FANG CHENG | PLoS ONE | 14 | 14 | |
25 | 2018 | Irradiation Enhances Abscopal Anti-tumor Effects of Antigen-Specific Immunotherapy through Regulating Tumor Microenvironment | Chang M.-C.; YU-LI CHEN ; Lin H.-W.; YING-CHENG CHIANG ; Chang C.-F.; Hsieh S.-F.; CHI-AN CHEN ; WEI-ZEN SUN ; WEN-FANG CHENG | Molecular Therapy | 31 | 28 | |
26 | 2018 | Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation | YU-LI CHEN ; Chang M.-C.; YING-CHENG CHIANG ; Lin H.-W.; Sun N.-Y.; CHI-AN CHEN ; WEI-ZEN SUN ; WEN-FANG CHENG | Cancer Letters | 32 | 29 | |
27 | 2017 | Risk factors associated with failure of treatment for cesarean scar pregnancy | YING-CHENG CHIANG ; YI-AN TU ; JEHN-HSIAHN YANG ; SHIN-YU LIN ; CHIEN-NAN LEE ; JIN-CHUNG SHIH | International Journal of Gynecology and Obstetrics | 11 | 10 | |
28 | 2017 | Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study | YING-CHENG CHIANG ; Chen Y.-Y.; Hsieh S.-F.; CHUN-JU CHIANG ; You S.-L.; WEN-FANG CHENG ; Lai M.-S.; CHI-AN CHEN ; Taiwan Cervical Cancer Prevention Surveillance Center | Taiwanese Journal of Obstetrics and Gynecology | 12 | 13 | |
29 | 2017 | Risk factors of hypersensitivity to carboplatin in patients with gynecologic malignancies | Tai Y.-H.; YI-JOU TAI ; HENG-CHENG HSU ; Lee S.-P.; Chen Y.-Y.; YING-CHENG CHIANG ; YU-LI CHEN ; CHI-AN CHEN ; WEN-FANG CHENG | Frontiers in Pharmacology | 10 | 9 | |
30 | 2017 | Malignant transformation of ovarian mature cystic teratoma into squamous cell carcinoma: A taiwanese gynecologic oncology group (TGOG) study | Chiang A.-J.; Chen M.-Y.; Weng C.-S.; Lin H.; Lu C.-H.; Wang P.-H.; Huang Y.-F.; YING-CHENG CHIANG ; Yu M.-H.; Chang C.-L. | Journal of Gynecologic Oncology | 36 | 28 | |
31 | 2016 | Anti-CD40 antibody and toll-like receptor 3 ligand restore dendritic cell-mediated anti-tumor immunity suppressed by morphine | Chang M.-C.; YU-LI CHEN ; YING-CHENG CHIANG ; YA-JUNG CHENG ; Jen Y.-W.; CHI-AN CHEN ; WEN-FANG CHENG ; WEI-ZEN SUN | American Journal of Cancer Research | 9 | ||
32 | 2016 | Mesothelin-specific cell-based vaccine generates antigen-specific immunity and potent antitumor effects by combining with IL-12 immunomodulator | Chang M.-C.; YU-LI CHEN ; YING-CHENG CHIANG ; Chen T.-C.; Tang Y.-C.; CHI-AN CHEN ; WEI-ZEN SUN ; WEN-FANG CHENG | Gene Therapy | 16 | 16 | |
33 | 2016 | Genomewide copy number analysis of Müllerian adenosarcoma identified chromosomal instability in the aggressive subgroup | JEN-CHIEH LEE ; TZU-PIN LU ; Changou C.A.; Liang C.-W.; Huang H.-N.; Lauria A.; Huang H.-Y.; Lin C.-Y.; YING-CHENG CHIANG ; Davidson B.; Lin M.-C.; KUAN-TING KUO | Modern Pathology | 23 | 21 | |
34 | 2015 | Standardized uptake value and apparent diffusion coefficient of endometrial cancer evaluated with integrated whole-body PET/MR: Correlation with pathological prognostic factors | I-LUN SHIH ; RUOH-FANG YEN ; CHI-AN CHEN ; BANG-BIN CHEN ; Wei S.-Y.; WEN-CHUN CHANG ; BOR-CHING SHEU ; WEN-FANG CHENG ; YAO-HUI TSENG ; Chen X.-J.; CHI-HAU CHEN ; LING-HUNG WEI ; YING-CHENG CHIANG ; PAO-LING TORNG ; MEN-LUH YEN ; TIFFANY TING-FANG SHIH | Journal of Magnetic Resonance Imaging | 44 | 38 | |
35 | 2015 | Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expression | Huang H.-N.; Lin M.-C.; LI-HUI TSENG ; YING-CHENG CHIANG ; LIANG-IN LIN ; YU-FENG LIN ; Huang H.-Y.; KUAN-TING KUO | Histopathology | 32 | 29 | |
36 | 2015 | Gene methylation profiles as prognostic markers in ovarian clear cell and endometrioid adenocarcinomas | CHI-AN CHEN ; YING-CHENG CHIANG ; Chang M.-C.; Hu Y.-H.; You S.-L.; Cheng Y.-Y.K.; Chou C.-Y.; WEN-FANG CHENG | American Journal of Translational Research | 8 | ||
37 | 2015 | Overexpression of CHI3L1 is associated with chemoresistance and poor outcome of epithelial ovarian carcinoma | YING-CHENG CHIANG ; Lin H.-W.; Chang C.-F.; Chang M.-C.; Fu C.-F.; Chen T.-C.; Hsieh S.-F.; CHI-AN CHEN ; WEN-FANG CHENG | Oncotarget | 26 | 26 | |
38 | 2015 | Outcome of patients with recurrent adult-type granulosa cell tumors - A Taiwanese Gynecologic Oncology Group study | Wang P.-H.; Sun H.-D.; Lin H.; Wang K.-L.; Liou W.-S.; Hung Y.-C.; YING-CHENG CHIANG ; Lu C.-H.; Lai H.-C.; Chang T.-C.; Yen M.-S.; CHI-AN CHEN ; Lai C.-H.; Yu M.-S.; Chou C.-Y.; Chang C.-L.; Huang K.-F.; Ho C.-M.; Chu T.-Y.; Wang P-H.; Liu F-S.; Kan Y.-Y.; Wu C.-H.; Taiwanese Gynecologic Oncology Group | Taiwanese Journal of Obstetrics and Gynecology | 11 | 11 | |
39 | 2015 | Establishment of a New Ovarian Cancer Cell Line CA5171 | YING-CHENG CHIANG ; WEN-FANG CHENG ; Chang M.-C.; TZU-PIN LU ; KUAN-TING KUO ; Lin H.-P.; CHANG-YAO HSIEH ; CHI-AN CHEN | Reproductive Sciences | 5 | 6 | |
40 | 2015 | Molecular alterations in endometrial and ovarian clear cell carcinomas: Clinical impacts of telomerase reverse transcriptase promoter mutation | Huang H.-N.; YING-CHENG CHIANG ; WEN-FANG CHENG ; CHI-AN CHEN ; Lin M.-C.; KUAN-TING KUO | Modern Pathology | 25 | 22 | |
41 | 2014 | Chromosome 20q13.2 ZNF217 locus amplification correlates with decreased E-cadherin expression in ovarian clear cell carcinoma with PI3K-Akt pathway alterations | Huang H.-N.; Huang W.-C.; CHING-HUNG LIN ; YING-CHENG CHIANG ; Huang H.-Y.; KUAN-TING KUO | Human Pathology | 18 | 20 | |
42 | 2014 | Impact of management on the prognosis of pure uterine papillary serous cancer - A Taiwanese Gynecologic Oncology Group (TGOG) study | Huang C.-Y.; Tang Y.-H.; YING-CHENG CHIANG ; Wang K.-L.; Fu H.-C.; Ke Y.-M.; Lau H.-Y.; Hsu K.-F.; Wu C.-H.; WEN-FANG CHENG | Gynecologic Oncology | 29 | 26 | |
43 | 2014 | Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations and ZNF217 amplification in ovarian clear cell carcinoma | Huang H.-N.; Lin M.-C.; Huang W.-C.; YING-CHENG CHIANG ; KUAN-TING KUO | Modern Pathology | 66 | 60 | |
44 | 2013 | Trends in incidence and survival outcome of epithelial ovarian cancer: 30-year national population-based registry in Taiwan | YING-CHENG CHIANG ; CHI-AN CHEN ; CHUN-JU CHIANG ; Hsu T.-H.; Lin M.-C.; You S.-L.; WEN-FANG CHENG ; Lai M.-S. | Journal of Gynecologic Oncology | 86 | 89 | |
45 | 2013 | Epigenetic silencing of BLU through interfering apoptosis results in chemoresistance and poor prognosis of ovarian serous carcinoma patients | YING-CHENG CHIANG ; Chang M.-C.; Chen P.-J.; Wu M.-M.; CHANG-YAO HSIEH ; WEN-FANG CHENG ; CHI-AN CHEN | Endocrine-Related Cancer | 19 | 19 | |
46 | 2013 | Sertoli-Leydig cell tumors of the ovary: A Taiwanese Gynecologic Oncology Group study | Weng C.-S.; Chen M.-Y.; Wang T.-Y.; Tsai H.-W.; Hung Y.-C.; Yu K.-J.; YING-CHENG CHIANG ; Lin H.; Lu C.-H.; Chou H.-H. | Taiwanese Journal of Obstetrics and Gynecology | 29 | 22 | |
47 | 2013 | High-risk human papillomavirus, other than type 16/18, in predominantly older Taiwanese women with high-grade cervical preinvasive lesions | YING-CHENG CHIANG ; WEN-FANG CHENG ; YU-LI CHEN ; Chang M.-C.; CHANG-YAO HSIEH ; Lin M.-C.; CHI-AN CHEN | Taiwanese Journal of Obstetrics and Gynecology | 9 | 9 | |
48 | 2012 | Brain metastases from epithelial ovarian carcinoma: Evaluation of prognosis and managements - A Taiwanese Gynecologic Oncology Group (TGOG) Study | YING-CHENG CHIANG ; Qiu J.-T.; Chang C.-L.; Wang P.-H.; Ho C.-M.; Lin W.-C.; Huang Y.-F.; Lin H.; Lu C.-H.; Chou C.-Y. | Gynecologic Oncology | 14 | 14 | |
49 | 2012 | Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response | YU-LI CHEN ; Chang M.-C.; Huang C.-Y.; YING-CHENG CHIANG ; Lin H.-W.; CHI-AN CHEN ; CHANG-YAO HSIEH ; WEN-FANG CHENG | Molecular Oncology | 107 | 103 | |
50 | 2012 | Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways | Chang M.-C.; CHI-AN CHEN ; Chen P.-J.; YING-CHENG CHIANG ; YU-LI CHEN ; TSUI-LIEN MAO ; Lin H.-W.; Lin Chiang W.-H.; WEN-FANG CHENG | Biochemical Journal | 113 | 112 | |
51 | 2012 | A long-term follow-up study of 176 cases with adult-type ovarian granulosa cell tumors | Sun H.-D.; Lin H.; Jao M.-S.; Wang K.-L.; Liou W.-S.; Hung Y.-C.; YING-CHENG CHIANG ; Lu C.-H.; Lai H.C.; Yu M.-H. | Gynecologic Oncology | 90 | 82 | |
52 | 2012 | New primers for methylation-specific polymerase chain reaction enhance specificity of detecting STAT1 methylation | Chang M.-C.; YING-CHENG CHIANG ; Ho C.-M.; YU-LI CHEN ; CHI-AN CHEN ; WEN-FANG CHENG ; Chou C.-Y. | Taiwanese Journal of Obstetrics and Gynecology | 5 | 4 | |
53 | 2012 | Cord blood stem-cell-derived dendritic cells generate potent antigen-specific immune responses and anti-tumour effects | Chang M.-C.; CHIEN-NAN LEE ; YU-LI CHEN ; YING-CHENG CHIANG ; WEI-ZEN SUN ; Hu Y.-H.; CHI-AN CHEN ; WEN-FANG CHENG | Clinical Science | 11 | 11 | |
54 | 2011 | Impact of various treatment modalities on the outcome of stage IB1-IIA cervical adenocarcinoma | YU-LI CHEN ; Ho C.-M.; CHI-AN CHEN ; YING-CHENG CHIANG ; Huang C.-Y.; CHANG-YAO HSIEH ; WEN-FANG CHENG | International Journal of Gynecology and Obstetrics | 6 | 6 | |
55 | 2010 | Metronomic chemotherapy enhances antitumor effects of cancer vaccine by depleting regulatory T lymphocytes and inhibiting tumor angiogenesis | CHI-AN CHEN ; Ho C.-M.; Chang M.-C.; WEI-ZEN SUN ; YU-LI CHEN ; YING-CHENG CHIANG ; Syu M.-H.; CHANG-YAO HSIEH ; WEN-FANG CHENG | Molecular Therapy | 82 | 72 | |
56 | 2009 | Noncarrier naked antigen-specific DNA vaccine generates potent antigen-specific immunologic responses and antitumor effects | CHI-AN CHEN ; Chang M.-C.; WEI-ZEN SUN ; YU-LI CHEN ; YING-CHENG CHIANG ; CHANG-YAO HSIEH ; Chen S.M.; PO-NI HSIAO ; WEN-FANG CHENG | Gene Therapy | 15 | 13 | |
57 | 2009 | High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma | WEN-FANG CHENG ; Huang C.-Y.; Chang M.-C.; Hu Y.-H.; YING-CHENG CHIANG ; YU-LI CHEN ; CHANG-YAO HSIEH ; CHI-AN CHEN | British Journal of Cancer | 117 | 112 | |
58 | 2008 | Synchronous primary cancers of the endometrium and ovary | YING-CHENG CHIANG ; CHI-AN CHEN ; Huang C.-Y.; CHANG-YAO HSIEH ; WEN-FANG CHENG | International Journal of Gynecological Cancer | 58 | 54 | |
59 | 2008 | 'Big-eyed frog' sign on spatiotemporal image correlation (STIC) in the antenatal diagnosis of transposition of the great arteries | JIN-CHUNG SHIH ; MING-KWANG SHYU ; Su Y.N; YING-CHENG CHIANG ; Lin C.H; CHIEN-NAN LEE | Ultrasound in Obstetrics and Gynecology | 21 | 13 | |
60 | 2006 | Prenatal diagnosis of congenital left ventricular aneurysm by four-dimensional ultrasonography with spatio-temporal image correlation (STIC) [1] | YING-CHENG CHIANG ; Yang C.-K.; JIN-CHUNG SHIH ; CHIEN-NAN LEE | Ultrasound in Obstetrics and Gynecology | 11 | 11 | |
61 | 2006 | Tuberculosis peritonitis | Hsieh L.-C.; YING-CHENG CHIANG ; LIN-HUNG WEI ; WEN-JENG LEE ; KAO-LANG LIU | Surgery | 1 | 1 | |
62 | 2006 | Septic shock after conservative management for placenta accreta | YING-CHENG CHIANG ; JIN-CHUNG SHIH ; CHIEN-NAN LEE | Taiwanese Journal of Obstetrics and Gynecology | 21 | 0 | |
63 | 2006 | Tongue teratoma - A rare form of fetal extragonadal teratoma diagnosed at 30 weeks' gestation [3] | YING-CHENG CHIANG ; JIN-CHUNG SHIH ; STEVEN SHINN-FORNG PENG ; WEI-CHUNG HSU ; CHIEN-NAN LEE | Ultrasound in Obstetrics and Gynecology | 10 | 7 |